Christine N. Kay, MD is a vitreoretinal specialist and assistant professor of Ophthalmology at the University of Florida. She completed her undergraduate degree in neurobiology at Harvard University and her medical degree at the University of Florida. After completing a transitional internship at the Roanoke Carilion Memorial Hospital, she completed her Ophthalmology residency training at the University of South Florida, and her vitreoretinal fellowship at the University of Iowa. Dr. Kay is board certified by the American Board of Ophthalmology and is a member of the American Academy of Ophthalmology and the American Society of Retinal Specialists.

At the University of Florida, Dr. Kay is the clinical research director for the vitreoretinal department and the vitreoretinal fellowship director. She evaluates and treats multiple retinal problems including diabetic eye disease, retinal vascular occlusions, macular edema, uveitis, macular degeneration, epiretinal membranes and macular holes, retinal tears and detachments, and has a particular interest in inherited retinal disease, genetic testing and gene therapy, and electrophysiology. Her particular research focus is in developing and optimizing gene therapy delivery systems for inherited retinal diseases. She has a career development award from the Foundation Fighting Blindness for research on genetic therapy for Achromatopsia, a disease affecting color vision and central vision.

Dr. Kay directs the electrophysiology service and has created an inherited retinal disease-specific clinic here at the University of Florida and is recruiting patients with retinitis pigmentosa, Stargardt disease, Leber congenital amaurosis, choroideremia, achromatopsia or other cone-related disorders, and any other inherited retinal diseases.